Scientists develop new natural killer cell strategy to target HIV
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
unaids12h
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them
By paralyzing frontline response efforts led by community groups, the US decision to freeze funding is weakening health systems across the Global South. The freeze not only jeopardizes precious gains ...
Monthly Prescribing Reference10h
Twice-Yearly Lenacapavir Gets Priority Review For HIV PrEP
The Food and Drug Administration (FDA) has accepted under Priority Review the New Drug Application (NDA) for lenacapavir, a long-acting HIV-1 capsid inhibitor, for the prevention of HIV as ...
How Trump’s policies could reverse decades of progress in Latin America’s HIV response
It was nearly 30 years ago when Rosember Lopez received a life-altering diagnosis: He was HIV positive. With scant government ...
MarketWatch14h
U.K. 10 Year Gilt
Spain 10 Year Government Bond-0.027 3.097% ...
emjreviews.com20h
Cytokine Markers Predict Mortality in Advanced HIV Cases
Researchers have identified key immunological markers associated with mortality in hospitalised people living with HIV/AIDS.